Marketing in healthcare is usually judged on lead volume, which is the one metric that can be bought cheaply and means least. Drapto ties every channel and campaign to the invoices it produced.
Anyone can buy enquiries. Patients are harder.
The channel that looks busiest on a lead report is frequently the one producing the fewest patients who pay. Without tying spend to invoices, that gap stays invisible until the budget review.
Website, search advertising, social, referring doctors, corporate accounts and walk-ins are each measured on the revenue they produced — which is the only comparison that treats offline referral sources fairly.
Blended acquisition cost hides the campaign quietly wasting money. Splitting by channel and campaign, with conversion tracked from enquiry to first invoice, shows exactly where the loss happens.
Arguing for spend with revenue attribution behind you is a different conversation from arguing with lead counts.
Ending a channel becomes a decision backed by data rather than a disagreement with the owner.
Knowing cost per acquired patient by campaign makes increasing budget a calculation rather than a hope.
Referring doctors and corporate accounts are measured properly instead of being invisible next to digital.
Acquisition source is captured and carried to the patient record, so revenue that patient generates traces back to the channel that produced them.
No. Ad platforms report their own performance. Drapto reports what happened afterwards — whether those enquiries became patients who paid.
Yes, lead-to-patient conversion funnels show where enquiries are lost between first contact and first invoice.
Yes. Walk-ins, referring doctors and corporate accounts sit alongside digital channels in the same comparison.